Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Terminated 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Non-Hodgkin 70 Lymphoma, Large B-Cell, Diffuse 67 Lymphoma 66 Lymphoma, Follicular 59 Leukemia, Lymphocytic, Chronic, B-Cell 58 Lymphoma, B-Cell, Marginal Zone 30 Burkitt Lymphoma 30 Waldenstrom Macroglobulinemia 24 Lymphoma, Mantle-Cell 24 Lymphoma, B-Cell 24 Precursor Cell Lymphoblastic Leukemia-Lymphoma 22 Leukemia 19 Recurrence 17 Hodgkin Disease 12 Neoplasms 10 Lymphoma, Large-Cell, Immunoblastic 10 Multiple Myeloma 8 Leukemia, Prolymphocytic 8 Leukemia, Myeloid, Acute 8 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 7 Myelodysplastic Syndromes 7 Mycosis Fungoides 6 Lymphoma, T-Cell, Cutaneous 6 Leukemia, Hairy Cell 6 Sezary Syndrome 5 Neoplasms, Plasma Cell 5 Lymphoma, Large-Cell, Anaplastic 5 Lymphoma, Extranodal NK-T-Cell 5 Intraocular Lymphoma 5 Dendritic Cell Sarcoma, Interdigitating 5

Interventions

pembrolizumab 51 Ipilimumab 49 Cyclophosphamide 43 Nivolumab 40 aldesleukin 30 Interleukin-2 23 Vemurafenib 20 fludarabine 19 Temozolomide 18 fludarabine phosphate 15 dabrafenib 15 trametinib 12 Radiosurgery 10 Dacarbazine 10 CTLA-4 Antigen 10 spartalizumab 9 cobimetinib 9 binimetinib 9 Radiotherapy 9 poly ICLC 7 encorafenib 7 Paclitaxel 7 atezolizumab 6 Introns 6 Biopsy 6 montanide ISA 51 5 Carboplatin 5 epacadostat 4 MART-1 Antigen 4 Interferon alpha-2 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Melanoma × Rituximab × Clear all

NCT01032122 2013-04-25

Rituximab in Metastatic Melanoma

Medical University of Vienna

Phase 1 Terminated

Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡